Comparative study of ropinirole and entacapone for the treatment of wearing-off in advanced Parkinson's disease patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2010
INTERVENTION: Increase dosage of ropinirole Addition of entacapone CONDITION: Parkinson's disease PRIMARY OUTCOME: Improvement of wearing‐off INCLUSION CRITERIA: 1. Parkinson disease patients who are in stage I to IV (mHY) at the on period. 2. Taking levodopa (300mg/day) and ropinirole (3‐6mg/day) for 4+ weeks at the fixed dosage and experienced wearing off phenomenon.
Epistemonikos ID: bc7f304e5c292d3b251c0e8cdaa429f31fc92164
First added on: Aug 22, 2024